

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.37354806 |
| 2 | angiotensin maturation (GO:0002003) | 9.24297328 |
| 3 | intestinal cholesterol absorption (GO:0030299) | 8.63545151 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 8.08074961 |
| 5 | drug catabolic process (GO:0042737) | 6.99031640 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.95963530 |
| 7 | drug transmembrane transport (GO:0006855) | 6.93106025 |
| 8 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.90694414 |
| 9 | drug transport (GO:0015893) | 6.46605597 |
| 10 | modified amino acid transport (GO:0072337) | 6.33857233 |
| 11 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.29448330 |
| 12 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.24115840 |
| 13 | urate metabolic process (GO:0046415) | 5.90810472 |
| 14 | adhesion of symbiont to host cell (GO:0044650) | 5.81927543 |
| 15 | virion attachment to host cell (GO:0019062) | 5.81927543 |
| 16 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.33687464 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.22909283 |
| 18 | regulation of systemic arterial blood pressure (GO:0003073) | 5.13705312 |
| 19 | actin filament depolymerization (GO:0030042) | 5.12207637 |
| 20 | flavonoid metabolic process (GO:0009812) | 5.10181339 |
| 21 | lysine catabolic process (GO:0006554) | 5.07212499 |
| 22 | lysine metabolic process (GO:0006553) | 5.07212499 |
| 23 | regulation of cellular extravasation (GO:0002691) | 5.04926991 |
| 24 | vitamin A metabolic process (GO:0006776) | 5.03396373 |
| 25 | peptide catabolic process (GO:0043171) | 4.90216288 |
| 26 | regulation of cGMP biosynthetic process (GO:0030826) | 4.89599152 |
| 27 | exogenous drug catabolic process (GO:0042738) | 4.85977738 |
| 28 | organic cation transport (GO:0015695) | 4.85107729 |
| 29 | renal absorption (GO:0070293) | 4.77178099 |
| 30 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.71758607 |
| 31 | adhesion of symbiont to host (GO:0044406) | 4.67372803 |
| 32 | phosphate ion transport (GO:0006817) | 4.64873551 |
| 33 | oligosaccharide catabolic process (GO:0009313) | 4.50531595 |
| 34 | urea cycle (GO:0000050) | 4.47910515 |
| 35 | polyol transport (GO:0015791) | 4.45106105 |
| 36 | sulfur compound transport (GO:0072348) | 4.36552063 |
| 37 | cellular response to nitric oxide (GO:0071732) | 4.35471417 |
| 38 | renal system process involved in regulation of blood volume (GO:0001977) | 4.34011982 |
| 39 | urea metabolic process (GO:0019627) | 4.28906310 |
| 40 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.25756721 |
| 41 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.25756721 |
| 42 | excretion (GO:0007588) | 4.23102311 |
| 43 | bile acid and bile salt transport (GO:0015721) | 4.21791527 |
| 44 | cellular glucuronidation (GO:0052695) | 4.21669423 |
| 45 | regulation of bile acid biosynthetic process (GO:0070857) | 4.18015694 |
| 46 | glucuronate metabolic process (GO:0019585) | 4.17828830 |
| 47 | uronic acid metabolic process (GO:0006063) | 4.17828830 |
| 48 | cysteine metabolic process (GO:0006534) | 4.13904766 |
| 49 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.13596450 |
| 50 | glycolipid catabolic process (GO:0019377) | 4.12087615 |
| 51 | NADH metabolic process (GO:0006734) | 4.10443528 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.08520747 |
| 53 | vitamin transmembrane transport (GO:0035461) | 4.08233745 |
| 54 | glycosphingolipid catabolic process (GO:0046479) | 4.06454741 |
| 55 | regulation of cGMP metabolic process (GO:0030823) | 4.06318079 |
| 56 | quaternary ammonium group transport (GO:0015697) | 4.03216017 |
| 57 | regulation of vitamin metabolic process (GO:0030656) | 3.97974934 |
| 58 | digestive system process (GO:0022600) | 3.97962656 |
| 59 | hormone catabolic process (GO:0042447) | 3.97604867 |
| 60 | antibacterial humoral response (GO:0019731) | 3.96257625 |
| 61 | nitrogen cycle metabolic process (GO:0071941) | 3.96222028 |
| 62 | glucose 6-phosphate metabolic process (GO:0051156) | 3.95937584 |
| 63 | sulfate transmembrane transport (GO:1902358) | 3.94639078 |
| 64 | glutathione biosynthetic process (GO:0006750) | 3.90396781 |
| 65 | fructose metabolic process (GO:0006000) | 3.89716369 |
| 66 | antimicrobial humoral response (GO:0019730) | 3.86064415 |
| 67 | trivalent inorganic anion homeostasis (GO:0072506) | 3.85052284 |
| 68 | phosphate ion homeostasis (GO:0055062) | 3.85052284 |
| 69 | phosphate ion transmembrane transport (GO:0035435) | 3.82802548 |
| 70 | diacylglycerol metabolic process (GO:0046339) | 3.81418168 |
| 71 | vitamin D metabolic process (GO:0042359) | 3.79571046 |
| 72 | response to nitric oxide (GO:0071731) | 3.79173053 |
| 73 | lipoprotein metabolic process (GO:0042157) | 3.78863147 |
| 74 | alkaloid metabolic process (GO:0009820) | 3.78687562 |
| 75 | peptide hormone processing (GO:0016486) | 3.77254145 |
| 76 | phospholipid efflux (GO:0033700) | 3.75228869 |
| 77 | transepithelial transport (GO:0070633) | 3.73453823 |
| 78 | fat-soluble vitamin metabolic process (GO:0006775) | 3.72808060 |
| 79 | response to phenylpropanoid (GO:0080184) | 3.70048913 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69925635 |
| 81 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69925635 |
| 82 | cellular response to reactive nitrogen species (GO:1902170) | 3.68459032 |
| 83 | digestion (GO:0007586) | 3.65972856 |
| 84 | positive regulation of pseudopodium assembly (GO:0031274) | 3.65760074 |
| 85 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.63900987 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 3.61929988 |
| 87 | negative regulation of sterol transport (GO:0032372) | 3.61929988 |
| 88 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.61349034 |
| 89 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.59486589 |
| 90 | cellular carbohydrate catabolic process (GO:0044275) | 3.58915400 |
| 91 | regulation of triglyceride catabolic process (GO:0010896) | 3.56661082 |
| 92 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.54823205 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 3.52545482 |
| 94 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.51236497 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 3.51178595 |
| 96 | regulation of cholesterol esterification (GO:0010872) | 3.49845589 |
| 97 | drug metabolic process (GO:0017144) | 3.48776882 |
| 98 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.47824820 |
| 99 | response to hepatocyte growth factor (GO:0035728) | 3.47824820 |
| 100 | negative regulation of digestive system process (GO:0060457) | 3.47589293 |
| 101 | bicarbonate transport (GO:0015701) | 3.47374176 |
| 102 | lipoprotein transport (GO:0042953) | 3.46920930 |
| 103 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.46135330 |
| 104 | response to mercury ion (GO:0046689) | 3.45497352 |
| 105 | drinking behavior (GO:0042756) | 3.45466690 |
| 106 | tricarboxylic acid metabolic process (GO:0072350) | 3.44836393 |
| 107 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.44188735 |
| 108 | vitamin biosynthetic process (GO:0009110) | 3.43997333 |
| 109 | cGMP biosynthetic process (GO:0006182) | 3.43881442 |
| 110 | peptide biosynthetic process (GO:0043043) | 3.41200193 |
| 111 | protein-lipid complex assembly (GO:0065005) | 3.40364103 |
| 112 | glycerol metabolic process (GO:0006071) | 3.40104117 |
| 113 | vitamin transport (GO:0051180) | 3.39015183 |
| 114 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.37715390 |
| 115 | carnitine transport (GO:0015879) | 3.35711751 |
| 116 | amino-acid betaine transport (GO:0015838) | 3.35711751 |
| 117 | cobalamin metabolic process (GO:0009235) | 3.34604906 |
| 118 | glyoxylate metabolic process (GO:0046487) | 3.32768637 |
| 119 | cGMP-mediated signaling (GO:0019934) | 3.32674858 |
| 120 | alditol metabolic process (GO:0019400) | 3.28909788 |
| 121 | arginine metabolic process (GO:0006525) | 3.27200330 |
| 122 | ceramide catabolic process (GO:0046514) | 3.27064333 |
| 123 | regulation of pseudopodium assembly (GO:0031272) | 3.27044080 |
| 124 | sterol homeostasis (GO:0055092) | 3.26936769 |
| 125 | aspartate family amino acid catabolic process (GO:0009068) | 3.26673325 |
| 126 | sphingomyelin metabolic process (GO:0006684) | 3.24424053 |
| 127 | beta-amyloid metabolic process (GO:0050435) | 3.22580901 |
| 128 | sexual reproduction (GO:0019953) | 3.22310358 |
| 129 | cholesterol homeostasis (GO:0042632) | 3.21081892 |
| 130 | glycosylceramide metabolic process (GO:0006677) | 3.20412352 |
| 131 | bile acid metabolic process (GO:0008206) | 3.19834237 |
| 132 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.19786377 |
| 133 | hydrogen peroxide catabolic process (GO:0042744) | 3.16539533 |
| 134 | sphingolipid catabolic process (GO:0030149) | 3.16246178 |
| 135 | positive regulation of lipid catabolic process (GO:0050996) | 3.16103930 |
| 136 | toxin transport (GO:1901998) | 3.15281221 |
| 137 | L-ascorbic acid metabolic process (GO:0019852) | 3.14570614 |
| 138 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.13194354 |
| 139 | endocrine process (GO:0050886) | 3.13194354 |
| 140 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.13194354 |
| 141 | sulfate transport (GO:0008272) | 3.12181803 |
| 142 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11529050 |
| 143 | positive regulation of cGMP metabolic process (GO:0030825) | 3.11265173 |
| 144 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.11041050 |
| 145 | midgut development (GO:0007494) | 3.09891015 |
| 146 | cholesterol efflux (GO:0033344) | 3.08932614 |
| 147 | short-chain fatty acid metabolic process (GO:0046459) | 3.08875367 |
| 148 | leukotriene metabolic process (GO:0006691) | 3.07579514 |
| 149 | amino acid transmembrane transport (GO:0003333) | 3.06314290 |
| 150 | mRNA modification (GO:0016556) | 3.04604024 |
| 151 | response to hydroperoxide (GO:0033194) | 3.04120312 |
| 152 | membrane lipid catabolic process (GO:0046466) | 3.03173068 |
| 153 | glutathione derivative metabolic process (GO:1901685) | 3.02373393 |
| 154 | glutathione derivative biosynthetic process (GO:1901687) | 3.02373393 |
| 155 | sodium ion transport (GO:0006814) | 3.01203862 |
| 156 | regulation of digestive system process (GO:0044058) | 3.00883494 |
| 157 | cytidine catabolic process (GO:0006216) | 3.00448902 |
| 158 | cytidine deamination (GO:0009972) | 3.00448902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.81944336 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.28757410 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.13159935 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36955683 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.32362195 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22959915 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09596695 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.06787944 |
| 9 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.96218057 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.62940976 |
| 11 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.59355642 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.57466872 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.47056108 |
| 14 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.23924340 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10641915 |
| 16 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.08733809 |
| 17 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.08560602 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04789738 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92322299 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85061134 |
| 21 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.79851156 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71691172 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.66713955 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.63812879 |
| 25 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58571567 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56856273 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56533214 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55586520 |
| 29 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46165657 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42981125 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40765635 |
| 32 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.39796787 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39259205 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37968912 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37763696 |
| 36 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37733180 |
| 37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33790866 |
| 38 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.32407373 |
| 39 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.31478474 |
| 40 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.28732506 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28682508 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28066648 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26562029 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25100520 |
| 45 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.24659683 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24239299 |
| 47 | SA1_27219007_Chip-Seq_Bcells_Human | 1.21682110 |
| 48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21332532 |
| 49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19272020 |
| 50 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.16133590 |
| 51 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.13382659 |
| 52 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.13079797 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12451921 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12288653 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12009842 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11920539 |
| 57 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07955892 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07481580 |
| 59 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07101060 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06839096 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06125322 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05370452 |
| 63 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05278982 |
| 64 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04931322 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03783786 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03572953 |
| 67 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02844826 |
| 68 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02046835 |
| 69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01420726 |
| 70 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00627019 |
| 71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00025781 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99355312 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98707755 |
| 74 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98577125 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98210714 |
| 76 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98098589 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98051149 |
| 78 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93948780 |
| 79 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93306946 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93114088 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93059788 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87976735 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87724392 |
| 84 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87721523 |
| 85 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.87421381 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86959343 |
| 87 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86285359 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85224157 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84620874 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84536822 |
| 91 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83610412 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83172436 |
| 93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83071642 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82949246 |
| 95 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82927993 |
| 96 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82836948 |
| 97 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.82297505 |
| 98 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82280910 |
| 99 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81724491 |
| 100 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81658002 |
| 101 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81066703 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80183007 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80077233 |
| 104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79869546 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79071599 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78870336 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78455112 |
| 108 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.77515361 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77485854 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76187017 |
| 111 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75986234 |
| 112 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.75842737 |
| 113 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.74791629 |
| 114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73751327 |
| 115 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.72408417 |
| 116 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.70750119 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70566568 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70508967 |
| 119 | CJUN_26792858_Chip-Seq_BT549_Human | 0.69796274 |
| 120 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.69718119 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68560380 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68445926 |
| 123 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.67782011 |
| 124 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67482346 |
| 125 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67144010 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67070938 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.67051732 |
| 128 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.66908723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 4.62793613 |
| 2 | MP0001666_abnormal_nutrient_absorption | 4.61953587 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.16899001 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.82413965 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.66206872 |
| 6 | MP0003252_abnormal_bile_duct | 3.36315443 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.19772487 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.08150567 |
| 9 | MP0005332_abnormal_amino_acid | 3.03252120 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.88325569 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.80317212 |
| 12 | MP0009643_abnormal_urine_homeostasis | 2.67812711 |
| 13 | MP0003878_abnormal_ear_physiology | 2.65888861 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.65888861 |
| 15 | MP0009840_abnormal_foam_cell | 2.63071875 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.62146930 |
| 17 | MP0001765_abnormal_ion_homeostasis | 2.36132520 |
| 18 | MP0005409_darkened_coat_color | 2.20554550 |
| 19 | MP0005365_abnormal_bile_salt | 2.15250963 |
| 20 | MP0000538_abnormal_urinary_bladder | 2.04739820 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.00755793 |
| 22 | MP0005360_urolithiasis | 10.7070791 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 1.97195324 |
| 24 | MP0005636_abnormal_mineral_homeostasis | 1.93675677 |
| 25 | MP0002136_abnormal_kidney_physiology | 1.89398448 |
| 26 | MP0004147_increased_porphyrin_level | 1.88675435 |
| 27 | MP0003866_abnormal_defecation | 1.78647596 |
| 28 | MP0003868_abnormal_feces_composition | 1.73516184 |
| 29 | MP0001756_abnormal_urination | 1.72933233 |
| 30 | MP0000462_abnormal_digestive_system | 1.71961654 |
| 31 | MP0003195_calcinosis | 1.66105072 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.63128334 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.60463361 |
| 34 | MP0005670_abnormal_white_adipose | 1.56980814 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.55706984 |
| 36 | MP0001188_hyperpigmentation | 1.49015162 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.34422223 |
| 38 | MP0005451_abnormal_body_composition | 1.30197991 |
| 39 | MP0003718_maternal_effect | 1.29982826 |
| 40 | MP0002796_impaired_skin_barrier | 1.28782962 |
| 41 | MP0002089_abnormal_postnatal_growth/wei | 1.21524216 |
| 42 | MP0001663_abnormal_digestive_system | 1.20687845 |
| 43 | MP0001664_abnormal_digestion | 1.15471805 |
| 44 | MP0005381_digestive/alimentary_phenotyp | 1.15246236 |
| 45 | MP0002822_catalepsy | 1.10574018 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.06554023 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.04835875 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.04403737 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04119841 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.02660039 |
| 51 | MP0003283_abnormal_digestive_organ | 1.02052850 |
| 52 | MP0010155_abnormal_intestine_physiology | 0.97343989 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 0.97169131 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 0.93508745 |
| 55 | MP0005448_abnormal_energy_balance | 0.93312628 |
| 56 | MP0000609_abnormal_liver_physiology | 0.92280235 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 0.91816159 |
| 58 | MP0000477_abnormal_intestine_morphology | 0.90447893 |
| 59 | MP0000537_abnormal_urethra_morphology | 0.90429802 |
| 60 | MP0001958_emphysema | 0.89259094 |
| 61 | MP0000230_abnormal_systemic_arterial | 0.87482930 |
| 62 | MP0005501_abnormal_skin_physiology | 0.86395817 |
| 63 | MP0002254_reproductive_system_inflammat | 0.84766971 |
| 64 | MP0004885_abnormal_endolymph | 0.82890859 |
| 65 | MP0001764_abnormal_homeostasis | 0.82131206 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 0.81553118 |
| 67 | MP0001873_stomach_inflammation | 0.80923233 |
| 68 | MP0002396_abnormal_hematopoietic_system | 0.80262550 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.79460714 |
| 70 | MP0006054_spinal_hemorrhage | 0.74573830 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.73264709 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 0.72808559 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.70451599 |
| 74 | MP0001849_ear_inflammation | 0.70274596 |
| 75 | MP0003879_abnormal_hair_cell | 0.69551196 |
| 76 | MP0009697_abnormal_copulation | 0.68977650 |
| 77 | MP0004947_skin_inflammation | 0.68255177 |
| 78 | MP0009785_altered_susceptibility_to | 0.67706529 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 0.63359186 |
| 80 | MP0004270_analgesia | 0.61171306 |
| 81 | MP0000490_abnormal_crypts_of | 0.60632957 |
| 82 | MP0002166_altered_tumor_susceptibility | 0.59722951 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.59649028 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.59202536 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.59134212 |
| 86 | MP0000678_abnormal_parathyroid_gland | 0.57762988 |
| 87 | MP0004858_abnormal_nervous_system | 0.57255810 |
| 88 | MP0002135_abnormal_kidney_morphology | 0.57072509 |
| 89 | MP0000249_abnormal_blood_vessel | 0.56974709 |
| 90 | MP0000467_abnormal_esophagus_morphology | 0.56815160 |
| 91 | MP0005535_abnormal_body_temperature | 0.55731989 |
| 92 | MP0005334_abnormal_fat_pad | 0.55207816 |
| 93 | MP0008260_abnormal_autophagy | 0.54707270 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.54069091 |
| 95 | MP0003724_increased_susceptibility_to | 0.53903866 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.53596240 |
| 97 | MP0005025_abnormal_response_to | 0.53273828 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.53085579 |
| 99 | MP0009764_decreased_sensitivity_to | 0.52705524 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.52367301 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.52277417 |
| 102 | MP0008872_abnormal_physiological_respon | 0.51991847 |
| 103 | MP0006138_congestive_heart_failure | 0.51861596 |
| 104 | MP0003436_decreased_susceptibility_to | 0.51390290 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 0.50331945 |
| 106 | MP0005266_abnormal_metabolism | 0.50047715 |
| 107 | MP0010678_abnormal_skin_adnexa | 0.49373971 |
| 108 | MP0001881_abnormal_mammary_gland | 0.48632980 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.48501760 |
| 110 | MP0008004_abnormal_stomach_pH | 0.47951348 |
| 111 | MP0003303_peritoneal_inflammation | 0.47554736 |
| 112 | MP0005310_abnormal_salivary_gland | 0.47158890 |
| 113 | MP0005166_decreased_susceptibility_to | 0.47018711 |
| 114 | MP0003329_amyloid_beta_deposits | 0.46292043 |
| 115 | MP0006082_CNS_inflammation | 0.44870691 |
| 116 | MP0001191_abnormal_skin_condition | 0.44176138 |
| 117 | MP0003953_abnormal_hormone_level | 0.44142960 |
| 118 | MP0000566_synostosis | 0.43388050 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.42934408 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.42533901 |
| 121 | MP0008469_abnormal_protein_level | 0.42327865 |
| 122 | MP0006036_abnormal_mitochondrial_physio | 0.40393504 |
| 123 | MP0002971_abnormal_brown_adipose | 0.40062347 |
| 124 | MP0009115_abnormal_fat_cell | 0.39176563 |
| 125 | MP0000604_amyloidosis | 0.38542526 |
| 126 | MP0000377_abnormal_hair_follicle | 0.37467402 |
| 127 | MP0000598_abnormal_liver_morphology | 0.37080291 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.36437485 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.35628585 |
| 130 | MP0003315_abnormal_perineum_morphology | 0.33649287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.25993710 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 6.12664727 |
| 3 | Metabolic alkalosis (HP:0200114) | 6.01227167 |
| 4 | * Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.73001708 |
| 5 | Hypokalemic alkalosis (HP:0001949) | 5.65313590 |
| 6 | Abnormality of chloride homeostasis (HP:0011422) | 5.52967275 |
| 7 | Abnormal urine output (HP:0012590) | 5.29037046 |
| 8 | Hypomagnesemia (HP:0002917) | 5.20312169 |
| 9 | Abnormality of renal excretion (HP:0011036) | 4.97580294 |
| 10 | Abnormality of magnesium homeostasis (HP:0004921) | 4.96865872 |
| 11 | Gout (HP:0001997) | 4.96761248 |
| 12 | Polyuria (HP:0000103) | 4.93000485 |
| 13 | Proximal tubulopathy (HP:0000114) | 4.61697570 |
| 14 | Malnutrition (HP:0004395) | 4.51924235 |
| 15 | Ileus (HP:0002595) | 4.51621080 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 4.47784080 |
| 17 | Abnormality of purine metabolism (HP:0004352) | 4.41916664 |
| 18 | Abnormality of urine glucose concentration (HP:0011016) | 4.36093404 |
| 19 | Glycosuria (HP:0003076) | 4.36093404 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 4.07364866 |
| 21 | Polydipsia (HP:0001959) | 3.97933121 |
| 22 | Abnormal drinking behavior (HP:0030082) | 3.97933121 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.94789953 |
| 24 | Hyperuricemia (HP:0002149) | 3.90128624 |
| 25 | Increased purine levels (HP:0004368) | 3.90128624 |
| 26 | Alkalosis (HP:0001948) | 3.85987757 |
| 27 | Hyperaldosteronism (HP:0000859) | 3.85677319 |
| 28 | Widely patent fontanelles and sutures (HP:0004492) | 3.78895280 |
| 29 | Tetany (HP:0001281) | 3.64943409 |
| 30 | Acanthocytosis (HP:0001927) | 3.53763260 |
| 31 | Hyperphosphaturia (HP:0003109) | 3.50299086 |
| 32 | Renal salt wasting (HP:0000127) | 3.47525186 |
| 33 | Generalized aminoaciduria (HP:0002909) | 3.41774230 |
| 34 | Hypercalciuria (HP:0002150) | 3.41240440 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 3.41091324 |
| 36 | Dehydration (HP:0001944) | 3.35565807 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.34625020 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.30653637 |
| 39 | Decreased circulating renin level (HP:0003351) | 3.22472477 |
| 40 | Abnormal urine phosphate concentration (HP:0012599) | 3.22002333 |
| 41 | Ketoacidosis (HP:0001993) | 3.20765759 |
| 42 | Hypokalemia (HP:0002900) | 3.19850126 |
| 43 | Potter facies (HP:0002009) | 3.17940529 |
| 44 | Facial shape deformation (HP:0011334) | 3.17940529 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 3.16599176 |
| 46 | Steatorrhea (HP:0002570) | 3.15700641 |
| 47 | Congenital sensorineural hearing impairment (HP:0008527) | 3.14364610 |
| 48 | Posterior subcapsular cataract (HP:0007787) | 3.11999922 |
| 49 | * Nephrolithiasis (HP:0000787) | 3.03222918 |
| 50 | Hyperparathyroidism (HP:0000843) | 2.91606760 |
| 51 | Hypophosphatemia (HP:0002148) | 2.83800900 |
| 52 | * Hyperglycinuria (HP:0003108) | 2.79127007 |
| 53 | Enlarged epiphyses (HP:0010580) | 2.77866031 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.76262795 |
| 55 | Renal tubular acidosis (HP:0001947) | 2.74821310 |
| 56 | Confusion (HP:0001289) | 2.74092440 |
| 57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.72175406 |
| 58 | Delayed epiphyseal ossification (HP:0002663) | 2.71001626 |
| 59 | Cupped ribs (HP:0000887) | 2.66550727 |
| 60 | Villous atrophy (HP:0011473) | 2.61496600 |
| 61 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.61496600 |
| 62 | Abnormality of potassium homeostasis (HP:0011042) | 2.61246537 |
| 63 | Focal segmental glomerulosclerosis (HP:0000097) | 2.60058175 |
| 64 | Metabolic acidosis (HP:0001942) | 2.60030318 |
| 65 | Chronic diarrhea (HP:0002028) | 2.56213439 |
| 66 | Eczematoid dermatitis (HP:0000976) | 2.56170235 |
| 67 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.55751329 |
| 68 | Fat malabsorption (HP:0002630) | 2.52691329 |
| 69 | Xanthomatosis (HP:0000991) | 2.48981894 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.46482811 |
| 71 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.45621817 |
| 72 | Abnormality of the costochondral junction (HP:0000919) | 2.45413469 |
| 73 | Thin bony cortex (HP:0002753) | 2.44244063 |
| 74 | Ketosis (HP:0001946) | 2.43215127 |
| 75 | Abnormality of vitamin B metabolism (HP:0004340) | 2.36530110 |
| 76 | Abdominal distention (HP:0003270) | 2.35637412 |
| 77 | B lymphocytopenia (HP:0010976) | 2.34628698 |
| 78 | Abnormality of B cell number (HP:0010975) | 2.34628698 |
| 79 | Subcapsular cataract (HP:0000523) | 2.32846200 |
| 80 | Epidermoid cyst (HP:0200040) | 2.32501522 |
| 81 | Hyperammonemia (HP:0001987) | 2.32086302 |
| 82 | Increased IgE level (HP:0003212) | 2.28046552 |
| 83 | Hyperphosphatemia (HP:0002905) | 2.24243099 |
| 84 | Wide cranial sutures (HP:0010537) | 2.22290282 |
| 85 | Cerebral palsy (HP:0100021) | 2.22143273 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.21444244 |
| 87 | Vascular calcification (HP:0004934) | 2.20954381 |
| 88 | Pigmentary retinal degeneration (HP:0001146) | 2.20469305 |
| 89 | Protuberant abdomen (HP:0001538) | 2.20149199 |
| 90 | Rickets (HP:0002748) | 2.19797561 |
| 91 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.19593404 |
| 92 | * Abnormality of glycine metabolism (HP:0010895) | 2.17638907 |
| 93 | * Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17638907 |
| 94 | Gastrointestinal dysmotility (HP:0002579) | 2.17269777 |
| 95 | Abnormal tarsal ossification (HP:0008369) | 2.15300061 |
| 96 | Severe combined immunodeficiency (HP:0004430) | 2.13170838 |
| 97 | Metaphyseal cupping (HP:0003021) | 2.12835395 |
| 98 | Pancreatitis (HP:0001733) | 2.10653051 |
| 99 | Nausea (HP:0002018) | 2.10440269 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 2.07314828 |
| 101 | Adrenal overactivity (HP:0002717) | 2.06773068 |
| 102 | Hypotension (HP:0002615) | 2.05168494 |
| 103 | Mesangial abnormality (HP:0001966) | 2.04852072 |
| 104 | Nephrocalcinosis (HP:0000121) | 2.02751859 |
| 105 | Irritability (HP:0000737) | 2.00651221 |
| 106 | Multiple lipomas (HP:0001012) | 2.00469190 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 1.99758481 |
| 108 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99758481 |
| 109 | Vomiting (HP:0002013) | 1.98426844 |
| 110 | Poikilocytosis (HP:0004447) | 1.96373011 |
| 111 | Renal tubular dysfunction (HP:0000124) | 1.96077499 |
| 112 | Growth hormone excess (HP:0000845) | 1.94459453 |
| 113 | Hypolipoproteinemia (HP:0010981) | 1.93829856 |
| 114 | Abnormal glucose tolerance (HP:0001952) | 1.93627897 |
| 115 | Cardiovascular calcification (HP:0011915) | 1.93529251 |
| 116 | Abnormality of sodium homeostasis (HP:0010931) | 1.92073012 |
| 117 | Glomerulosclerosis (HP:0000096) | 1.91885083 |
| 118 | Hyponatremia (HP:0002902) | 1.91056552 |
| 119 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.91051777 |
| 120 | Paresthesia (HP:0003401) | 1.91040026 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90425782 |
| 122 | Combined immunodeficiency (HP:0005387) | 1.90234109 |
| 123 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.89476358 |
| 124 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.87654010 |
| 125 | Hypocalcemia (HP:0002901) | 1.86250985 |
| 126 | Thyroiditis (HP:0100646) | 1.85235253 |
| 127 | Glomerulonephritis (HP:0000099) | 1.85136870 |
| 128 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85000512 |
| 129 | * Hydroxyprolinuria (HP:0003080) | 1.83345774 |
| 130 | * Abnormality of proline metabolism (HP:0010907) | 1.83345774 |
| 131 | Megaloblastic anemia (HP:0001889) | 1.83229379 |
| 132 | Late onset (HP:0003584) | 1.82058458 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.81850331 |
| 134 | Abnormality of complement system (HP:0005339) | 1.81417730 |
| 135 | Hypoalbuminemia (HP:0003073) | 1.80416975 |
| 136 | Abnormal albumin level (HP:0012116) | 1.80416975 |
| 137 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80028705 |
| 138 | White forelock (HP:0002211) | 1.79933442 |
| 139 | Patchy hypopigmentation of hair (HP:0011365) | 1.75546276 |
| 140 | Symptomatic seizures (HP:0011145) | 1.73760344 |
| 141 | Complement deficiency (HP:0004431) | 1.71984451 |
| 142 | Nephritis (HP:0000123) | 1.70454612 |
| 143 | Lethargy (HP:0001254) | 1.68359733 |
| 144 | Metaphyseal irregularity (HP:0003025) | 1.68333986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.41559626 |
| 2 | WNK4 | 6.17255062 |
| 3 | WNK3 | 5.35634786 |
| 4 | OXSR1 | 5.10994079 |
| 5 | MST4 | 5.00983726 |
| 6 | FRK | 4.63545561 |
| 7 | MST1R | 3.36193168 |
| 8 | GRK6 | 3.06962381 |
| 9 | STK39 | 3.01170878 |
| 10 | LMTK2 | 2.41913127 |
| 11 | NME1 | 2.19948852 |
| 12 | MAP3K2 | 1.92105109 |
| 13 | AKT3 | 1.89097181 |
| 14 | PRKG2 | 1.86291059 |
| 15 | PTK6 | 1.79089038 |
| 16 | MAP3K10 | 1.70384171 |
| 17 | ERN1 | 1.67475397 |
| 18 | RIPK1 | 1.62334389 |
| 19 | EPHA3 | 1.55006070 |
| 20 | PRPF4B | 1.48283868 |
| 21 | MAP2K2 | 1.41620906 |
| 22 | TNIK | 1.40287661 |
| 23 | EPHA2 | 1.32489238 |
| 24 | STK10 | 1.29700142 |
| 25 | MAP3K12 | 1.24388998 |
| 26 | EPHA4 | 1.21862775 |
| 27 | PDK2 | 1.18485726 |
| 28 | EPHB1 | 1.15185474 |
| 29 | PDK3 | 1.15111150 |
| 30 | PDK4 | 1.15111150 |
| 31 | MAP3K7 | 1.12998117 |
| 32 | MET | 1.08451153 |
| 33 | STK38L | 1.06538842 |
| 34 | WNK1 | 1.03856176 |
| 35 | PTK2 | 1.03235867 |
| 36 | FGFR3 | 0.99311527 |
| 37 | NUAK1 | 0.96774688 |
| 38 | PRKCI | 0.96607916 |
| 39 | BCKDK | 0.96095769 |
| 40 | LRRK2 | 0.95286209 |
| 41 | STK24 | 0.95252298 |
| 42 | SGK494 | 0.90202392 |
| 43 | SGK223 | 0.90202392 |
| 44 | MAP3K3 | 0.87401187 |
| 45 | FGFR4 | 0.86984306 |
| 46 | EPHB2 | 0.85548909 |
| 47 | NLK | 0.83050752 |
| 48 | CDC42BPA | 0.80309776 |
| 49 | TESK2 | 0.80031363 |
| 50 | FER | 0.79524249 |
| 51 | TAOK1 | 0.78872078 |
| 52 | NEK1 | 0.76980623 |
| 53 | LATS1 | 0.75905594 |
| 54 | INSRR | 0.73032570 |
| 55 | SGK3 | 0.72579420 |
| 56 | TESK1 | 0.71913134 |
| 57 | PRKAA2 | 0.70830666 |
| 58 | PIK3CA | 0.69884396 |
| 59 | DYRK1B | 0.67317092 |
| 60 | ITK | 0.64494916 |
| 61 | MAPK11 | 0.63162573 |
| 62 | BMX | 0.58113849 |
| 63 | PDPK1 | 0.57526722 |
| 64 | PAK4 | 0.56372987 |
| 65 | KSR2 | 0.56142139 |
| 66 | BMPR2 | 0.55127456 |
| 67 | MAP4K1 | 0.54487742 |
| 68 | PRKAA1 | 0.53499938 |
| 69 | GSK3A | 0.52955221 |
| 70 | IRAK1 | 0.52262482 |
| 71 | MAP3K11 | 0.50590322 |
| 72 | RIPK4 | 0.49355522 |
| 73 | MAP2K6 | 0.47925616 |
| 74 | MATK | 0.47476314 |
| 75 | STK38 | 0.47442896 |
| 76 | RET | 0.45140828 |
| 77 | JAK1 | 0.44199813 |
| 78 | SCYL2 | 0.44193959 |
| 79 | PAK3 | 0.44096495 |
| 80 | ERBB2 | 0.43471644 |
| 81 | MAP3K8 | 0.43384511 |
| 82 | TAOK3 | 0.42658718 |
| 83 | MYLK | 0.42086257 |
| 84 | DAPK2 | 0.41520977 |
| 85 | PDK1 | 0.41398899 |
| 86 | YES1 | 0.41264091 |
| 87 | TBK1 | 0.40216847 |
| 88 | MAP3K1 | 0.39577324 |
| 89 | CSF1R | 0.37931847 |
| 90 | SGK2 | 0.37891185 |
| 91 | CAMK2D | 0.36965364 |
| 92 | CASK | 0.36842331 |
| 93 | MAP2K1 | 0.36314386 |
| 94 | IKBKE | 0.35543136 |
| 95 | CSK | 0.34335830 |
| 96 | TYK2 | 0.34197235 |
| 97 | CDK6 | 0.34152786 |
| 98 | DDR2 | 0.33650863 |
| 99 | ABL2 | 0.32798316 |
| 100 | BTK | 0.32690555 |
| 101 | MELK | 0.31093757 |
| 102 | IRAK3 | 0.30713584 |
| 103 | CAMK2G | 0.30586687 |
| 104 | ZAP70 | 0.29968203 |
| 105 | TRIB3 | 0.29795217 |
| 106 | MAPK15 | 0.29622226 |
| 107 | SYK | 0.29602529 |
| 108 | CAMK2B | 0.28613186 |
| 109 | NEK6 | 0.28501471 |
| 110 | SMG1 | 0.27669019 |
| 111 | PRKCD | 0.26595134 |
| 112 | PRKACG | 0.26572124 |
| 113 | PRKCA | 0.26259108 |
| 114 | TEC | 0.25654516 |
| 115 | PRKCQ | 0.24528778 |
| 116 | SRC | 0.23143088 |
| 117 | TTK | 0.21596010 |
| 118 | LYN | 0.21344175 |
| 119 | RPS6KA2 | 0.20948930 |
| 120 | CDK19 | 0.20364160 |
| 121 | STK11 | 0.19646052 |
| 122 | JAK2 | 0.19482618 |
| 123 | ICK | 0.18864705 |
| 124 | JAK3 | 0.18467792 |
| 125 | MAPKAPK2 | 0.18098402 |
| 126 | LCK | 0.17352978 |
| 127 | PIM2 | 0.15785360 |
| 128 | GRK1 | 0.15684238 |
| 129 | PRKD2 | 0.15103753 |
| 130 | MAP3K14 | 0.15069976 |
| 131 | CSNK1A1 | 0.14974827 |
| 132 | SGK1 | 0.14854030 |
| 133 | FYN | 0.14248535 |
| 134 | PRKCZ | 0.13663412 |
| 135 | NTRK1 | 0.11918399 |
| 136 | INSR | 0.11419580 |
| 137 | PDGFRA | 0.11302191 |
| 138 | ROCK1 | 0.10471224 |
| 139 | PIM1 | 0.09671622 |
| 140 | ERBB4 | 0.08830584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.23899536 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.02534572 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.90836405 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.22038072 |
| 5 | * Mineral absorption_Homo sapiens_hsa04978 | 3.05256498 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.91694094 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.69166832 |
| 8 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.48891438 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.47633004 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 2.33942081 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.33735404 |
| 12 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 2.18498178 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.17515350 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.00488034 |
| 15 | Galactose metabolism_Homo sapiens_hsa00052 | 1.97871836 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.92262098 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87519453 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.86023688 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85875333 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84625096 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84278934 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84027972 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67927010 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.64814447 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.59608342 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59250371 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59126247 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59105755 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57645304 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55004242 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47954352 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39952350 |
| 33 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.39038943 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.34717785 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.33398828 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30925075 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20876595 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.16161956 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14798488 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14651613 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12622288 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10931934 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10835811 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06122686 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01404477 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01332567 |
| 47 | Asthma_Homo sapiens_hsa05310 | 0.98656744 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95210326 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90139748 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86796431 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85453557 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.84272917 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74558886 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.73245094 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.71388381 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70743119 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66933986 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65915755 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65364116 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62338495 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60905306 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58743177 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58534716 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57943150 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54363923 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53248380 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53147705 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51314731 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51127491 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50300188 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50141567 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48612430 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47585346 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45439406 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45267485 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43290148 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41537595 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40929720 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39348924 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.39100973 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38318696 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36353337 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34182248 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32677700 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28950005 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28495312 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.28174876 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.26762427 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26363097 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24618795 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22743101 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.22349630 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22294825 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.21789974 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21484611 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21480604 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20697189 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19906545 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.18209830 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.16642537 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.16114815 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15632544 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15479575 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.15331233 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14352015 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.11348634 |
| 107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.10107635 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.08687900 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.07317153 |
| 110 | Insulin secretion_Homo sapiens_hsa04911 | 0.06908860 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06902812 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.05678997 |
| 113 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.05583276 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.05487814 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.04760469 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04170124 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.04021291 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.03626916 |
| 119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.03227791 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03221481 |
| 121 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.02351027 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.01737193 |
| 123 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.01099908 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.00527195 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | -0.0230631 |
| 126 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0212339 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0169948 |
| 128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.0002885 |

